BCAB

AS OF

Dec 5, 04:59 PM (EDT)

Price

$0.83

Change

-$0.02 (-2.35%)

Capitalization

48.57M

104 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

BCAB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

BioAtla (BCAB) Earnings Date & Reports

BioAtla Inc is a clinical-stage biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BCAB is expected to report earnings to fall 18.52% to -21 cents per share on March 19

Q4'25

Est.

$-0.22

Q3'25

Est.

$-0.27

Q2'25

Missed

by $0.06

Q1'25

Beat

by $0.13

Q4'24

Beat

by $0.08

The last earnings report on November 13 showed earnings per share of -27 cents, meeting the estimate of -27 cents. With 408.99K shares outstanding, the current market capitalization sits at 48.57M.

View a ticker or compare two or three

Compare

BCAB

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BCAB showed earnings on November 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading for BCAB

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

11085 Torreyana Road

Phone

+1 858 558-0708

Employees

Web

https://www.bioatla.com